Study of Human Coagulation Factor IX in patients with Haemophilia B

Trial Profile

Study of Human Coagulation Factor IX in patients with Haemophilia B

Planning
Phase of Trial: Phase I

Latest Information Update: 26 Sep 2016

At a glance

  • Drugs Factor IX (Primary)
  • Indications Haemophilia B
  • Focus Adverse reactions
  • Most Recent Events

    • 26 Sep 2016 New trial record
    • 19 Sep 2016 According to China Biologic Products, Inc media release, company plans to complete this study by 2018.
    • 19 Sep 2016 According to China Biologic Products, Inc media release, clinical trial application for FIX was officially accepted by the CFDA in December 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top